Summary
The energy-dependent conversion of methionine to S-adenosyl-L-methionine (SAMe) is catalysed by S-adenosyl-L-methionine synthetase (SAMe-synthetase) in the liver. In the hepatocyte, an equilibrium exists between the high and low molecular weight forms of SAMe-synthetase, which consist of a tetramer and a dimer, respectively, of a 48.5 kilodalton subunit. The 2 enzymic forms differ in their affinity for methionine and sensitivity to inhibition by pyrophosphate; 2 of the sulfhydryl groups of SAMe-synthetase have been identified as essential for the normal functioning of the enzyme.
In patients with liver cirrhosis, a marked reduction in the utilisation of the high molecular weight SAMe-synthetase and displacement of the equilibrium occur, the molecular mechanism of which has yet to be established. This loss of activity is associated with a delay in methionine clearance and impairment of the trans-sulphuration pathway, which normally eliminates excess methionine by oxidising homocysteine to sulphate anion. It is hypothesised that in normal liver function the essential sulfhydryl groups of SAMe-synthetase are protected from oxidation by glutathione, a by-product of the transsulphuration pathway. However, glutathione levels are reduced in liver cirrhosis, and this may result in increased oxidation of the essential sulfhydryl groups, and consequent inactivation of the enzyme. Thus, the trans-sulphuration pathway may play an important role in the maintenance of normal SAMe-synthetase activity.
Similar content being viewed by others
References
Cabrero C, Alemany S. Conversion of rat liver S-adenosyl-L-methionine synthetase from high-Mr to low-Mr form by Li Br. Biochimica et Biophysica Acta 952: 277–281, 1988
Cabrero C, Puerta J, Alemany S. Purification and comparison of two forms of S-adenosyl-L-methionine synthetase from rat liver. European Journal of Biochemistry 170: 299–304, 1987
Cabrero C, Martin-Duce A, Ortiz P, Alemany S, Mato JM. Specific loss of the high-molecular-weight form of S-adenosyl-L-methionine synthetase in human liver cirrhosis. Hepatology 8: 1530–1534, 1988
Cantoni GL. Biological methylation: selected aspects. Annual Review of Biochemistry 44: 435–451, 1975
Chawla RK, Lewis FW, Kutner MH, Bate DM, Roy RGB, et al. Plasma cysteine, cystine, and glutathione in cirrhosis. Gastroenterology 87: 770–776, 1984
Comporti M, Benedetti A, Chieli E. Studies on in vitro peroxidation of liver lipids in ethanol treated rats. Lipids 8: 498–502, 1973
Corrales F, Cabrero C, Pajares MA, Ortiz P, Duce AM, et al. Inactivation and dissociation of S-adenosylmethionine synthetase by modification of sulfhydryl groups and its possible occurrence in liver cirrhosis. Hepatology 11: 216–222, 1990
Feo F, Pascale R, Garcea R, Daino L, Pirisi L, et al. Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats. Toxicology and Applied Pharmacology 83: 331–341, 1986
Finkelstein JD, Kyele WL, Martin JJ, Pick AM. Activation of cystathionine synthase by adenosylmethionine and adenosylethionine. Biochemical and Biophysical Research Communications 66: 81–87, 1975
Finkelstein JD, Martin JJ. Methionine metabolism in mammals: adaptation to methionine excess. Journal of Biological Chemistry 261: 1582–1587, 1986
Gahl WA, Finkelstein JD, Mullen KD, Bernardini I, Martin JJ, et al. Hepatic methionine adenosyltransferase deficiency in a 31-year-old man. American Journal of Human Genetics 40: 39–49, 1987
Gahl WA, Bernardini I, Finkelstein JD, Tangerman A, Martin JJ, et al. Transsulfuration in an adult with hepatic methionine adenosyltransferase deficiency. Journal of Clinical Investigation 81: 390–397, 1988
Gaull GE, Rassin DK, Solomon GE, Harris RC, Sturman JA. Biochemical observations on so-called hereditary tyrosinemia. Pediatric Research 4: 337–344, 1970
Horowitz JH, Rypins EB, Henderson JM, Heymsfield SB, Moffitt SD, et al. Evidence for impairment of transulfuration pathway in cirrhosis. Gastroenterology 81: 668–675, 1981
Jocelyn PC. Biochemistry of the SH group: the occurrence, chemical properties, metabolism and biological function of thiols and disulphides. Academic Press, London and New York, 1972
Kaplowitz N. The importance and regulation of hepatic glutathione. Yale Journal of Biology and Medicine 54: 497–502, 1981
Kinsell LW, Harper HA, Marton HC, Michael GD, Weiss HA. Rate of disappearance from plasma of intravenously administered methionine in patients with liver damage. Science 106: 589–590, 1947
Kutzbach C, Stokstad CLR. Mammalian methylene-tetrahydrofolate reductase in rat liver by S-adenosyl-methionine. Biochimica et Biophysica Acta 139: 217–220, 1967
Lieber CS, Casini A, De Carli LM, Kim C, Lowe N, et al. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology 11: 165–172, 1990
Markham GD, Satishchandran C. Identification of the reactive sulfhydryl groups of S-adenosylmethionine synthetase. Journal of Biological Chemistry 262: 8666–8770, 1988
Martin-Duce C, Ortiz P, Cabrero C, Mato JM. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 8: 65–68, 1988
Mato J M, Alemany S. What is the function of phospholipid methylation? Biochemical Journal 213: 1–10, 1983
Matsumoto C, Suma Y, Tsukada K. Changes in the activities of S-adenosylmethionine synthetase isozymes from rat with dietary methionine. Journal of Biochemistry 95: 287–290, 1984
Mitchell AD, Benevenga NJ. The role of transamination in methionine oxidation in the rat. Journal of Nutrition 108: 67–78, 1978
Mudd SH, Poole JR. Labile methyl balances for normal humans on various dietary regimens. Metabolism — Clinical and Experimental 24: 721–735, 1975
Mudd SH, Ebert MH, Seriver CR. Labile methyl group balances in human: the role of sarcosine. Metabolism — Clinical and Experimental 29: 707–720, 1980
Okada G, Watanabe Y, Tsukada K. Changes in patterns of S-adenosylmethionine synthetase in fetal and postnatal rat liver. Cancer Research 40: 2895–2897, 1980
Okada G, Teraoka H, Tsukada K. Multiple species of mammalian S-adenosylmethionine synthetase. Partial purification and characterization. Biochemistry 20: 934–940, 1981
Stramentinoli G, Gulano M, Ideo G. Protective role of S-adenosyl-L-methionine on liver injury induced by D-galactosamine in rats. Biochemical Pharmacology 27: 1431–1433, 1978
Sullivan DH, Hoffman JL. Fractionation and kinetic properties of rat liver and kidney methionine adenosyltransferase isozymes. Biochemistry 22: 1636–1641, 1983
Tsukada K, Okada G. S-adenosylmethionine synthetase isozyme patterns from rat hepatoma induced by N-2-fluorenylacetamide. Biochemical and Biophysical Research Communications 94: 1078–1082, 1980
Vendemiale G, Altomare E, Trizio T, LeGrazie C, Di Padova C, et al. Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scandinavian Journal of Gastroenterology 24: 407–415, 1989
Videla LA, Iturriaga H, Pino ME, Bunout D, Valenzuela A, et al. Content of hepatic reduced glutathione in chronic alcoholic patients: influence of the length of abstinence and liver necrosis. Clinical Science 66: 283–290, 1984
Zeisel SH, Poole JR. Dietary intake of methionine: influence in mammals on brain S-adenosylmethionine. In Usdin E, et al. (Eds) Transmethylation, pp. 59–68, Elsevier, The Netherlands, 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mato, J.M., Corrales, F., Martin-Duce, A. et al. Mechanisms and Consequences of the Impaired Trans-Sulphuration Pathway in Liver Disease: Part I. Drugs 40 (Suppl 3), 58–64 (1990). https://doi.org/10.2165/00003495-199000403-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199000403-00006